Contactin 1, a Potential New Antigen Target in Membranous Nephropathy: A Case Report.
暂无分享,去创建一个
D. Santoro | G. Piccoli | A. Barreca | A. Mazzeo | M. Torreggiani | E. Longhitano | A. Toscano | H. Debiec | P. Ronco | M. Russo | Elisa Vegezzi
[1] H. Debiec,et al. Membranous nephropathy: current understanding of various causes in light of new target antigens , 2021, Current opinion in nephrology and hypertension.
[2] S. Sethi. New 'Antigens' in Membranous Nephropathy. , 2020, Journal of the American Society of Nephrology : JASN.
[3] D. Salant,et al. Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1 associated membranous nephropathy. , 2020, The Journal of clinical investigation.
[4] I. Koneczny. Update on IgG4-mediated autoimmune diseases: New insights and new family members. , 2020, Autoimmunity reviews.
[5] L. Kremer,et al. Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera , 2020, Journal of Neurology.
[6] G. Marfia,et al. Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP , 2019, Neurology(R) neuroimmunology & neuroinflammation.
[7] P. Bergh,et al. Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy , 2019, The Lancet Neurology.
[8] J. Devaux,et al. “Neuro‐renal syndrome” related to anti‐contactin‐1 antibodies , 2019, Muscle & nerve.
[9] J. Kira,et al. Chronic Inflammatory Demyelinating Polyneuropathy With Concurrent Membranous Nephropathy: An Anti-paranode and Podocyte Protein Antibody Study and Literature Survey , 2018, Front. Neurol..
[10] W. Couser. Primary Membranous Nephropathy. , 2017, Clinical journal of the American Society of Nephrology : CJASN.
[11] G. Sobue,et al. Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies , 2017, Journal of Neurology, Neurosurgery & Psychiatry.
[12] J. Devaux,et al. Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects. , 2016, Brain : a journal of neurology.
[13] R. Rojas-García,et al. Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins , 2015, Neurology: Neuroimmunology & Neuroinflammation.
[14] G. Remuzzi,et al. Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy. , 2015, Journal of the American Society of Nephrology : JASN.
[15] J. Klein,et al. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. , 2015, The New England journal of medicine.
[16] M. Uhlén,et al. Neuronal proteins are novel components of podocyte major processes and their expression in glomerular crescents supports their role in crescent formation. , 2013, Kidney international.
[17] L. Steinman,et al. Innate and Adaptive Autoimmunity Directed to the Central Nervous System , 2009, Neuron.
[18] David M. Beck,et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. , 2009, The New England journal of medicine.
[19] Elior Peles,et al. Contactin Orchestrates Assembly of the Septate-like Junctions at the Paranode in Myelinated Peripheral Nerve , 2001, Neuron.
[20] D. Bronson,et al. Identification and characterization of the human cell adhesion molecule contactin. , 1994, Brain research. Molecular brain research.